Free for academic non-profit institutions. Other users need a Commercial license
The protein encoded by this gene is involved in the sodium-independent transport and excretion of organic anions, some of which are potentially toxic. The encoded protein is an integral membrane protein and is found mainly in the kidney and in the placenta, where it may act to prevent potentially harmful organic anions from reaching the fetus. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A11 (Solute Carrier Family 22 Member 11) is a Protein Coding gene. Diseases associated with SLC22A11 include Danubian Endemic Familial Nephropathy and Gout. Among its related pathways are Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds and Uricosurics Pathway, Pharmacodynamics. Gene Ontology (GO) annotations related to this gene include transmembrane transporter activity and organic anion transmembrane transporter activity. An important paralog of this gene is SLC22A12.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005452 | inorganic anion exchanger activity | IDA | 15037815 |
GO:0005515 | protein binding | IPI | 16236806 |
GO:0008514 | organic anion transmembrane transporter activity | IDA | 15102942 |
GO:0015347 | sodium-independent organic anion transmembrane transporter activity | IDA | 10660625 |
GO:0022857 | transmembrane transporter activity | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005886 | plasma membrane | TAS | -- |
GO:0005887 | integral component of plasma membrane | IDA | 10660625 |
GO:0009897 | external side of plasma membrane | IDA | 15102942 |
GO:0016020 | membrane | IEA | -- |
GO:0016021 | integral component of membrane | IEA | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006811 | ion transport | IEA | -- |
GO:0015698 | inorganic anion transport | IEA | -- |
GO:0015711 | organic anion transport | IBA,IDA | 10660625 |
GO:0046415 | urate metabolic process | IMP | 19503597 |
GO:0055085 | transmembrane transport | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Probenecid | Approved, Investigational | Pharma | Target, Transporter, inhibitor, blocker | 45 | ||
Methotrexate | Approved | Pharma | Transporter, substrate | Folate antagonist,inhibits DFHR | 1874 | |
Bumetanide | Approved | Pharma | Transporter, inhibitor | NKCC cotransporter inhibitor, Na+/2Cl-/K+ (NKCC) symporter inhibitor | 29 | |
Cefalotin | Approved, Investigational, Vet_approved | Pharma | Transporter, inhibitor | 0 | ||
Cefamandole | Approved, Experimental | Pharma | Transporter, inhibitor | 2 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
4'-Hydroxydiclofenac |
|
64118-84-9 | ||||
5'-Hydroxypiroxicam |
|
77459-78-0 |
ExUns: | 1a | · | 1b | · | 1c | ^ | 2 | ^ | 3 | ^ | 4a | · | 4b | ^ | 5 | ^ | 6a | · | 6b | ^ | 7a | · | 7b | · | 7c | ^ | 8a | · | 8b | ^ | 9 | ^ | 10 | ^ | 11 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | |||||||||||||||||||||||||||||||
SP2: | - | - | - | - | - | - | |||||||||||||||||||||||||||||
SP3: | - | - | - | - | |||||||||||||||||||||||||||||||
SP4: | |||||||||||||||||||||||||||||||||||
SP5: | |||||||||||||||||||||||||||||||||||
SP6: | - | - |
This gene was present in the common ancestor of animals.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | SLC22A11 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | SLC22A11 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | SLC22A11 30 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | SLC22A11 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | -- 31 |
|
OneToMany | |
Fruit Fly (Drosophila melanogaster) |
Insecta | CG8654 32 |
|
|
|
Worm (Caenorhabditis elegans) |
Secernentea | ZK455.8a 32 |
|
|
|
ZK455.8b 32 |
|
|
|||
K05F1.6 32 |
|
|
SNP ID | Clinical significance and condition | Chr 11 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
rs72559736 | Benign: not provided | 64,556,035(+) |
C/T NM_018484.4(SLC22A11):c.36C>T (p.Gly12=) |
SYNONYMOUS | |
rs77872171 | Benign: not provided | 64,556,062(+) |
G/A NM_018484.4(SLC22A11):c.63G>A (p.Val21=) |
SYNONYMOUS | |
rs12785832 | - |
p.Val155Gly |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv1965n54 | CNV | loss | 21841781 |
esv2422214 | CNV | deletion | 17116639 |
nsv825945 | CNV | gain | 20364138 |
nsv832188 | CNV | gain | 17160897 |
Disorder | Aliases | PubMed IDs |
---|---|---|
danubian endemic familial nephropathy |
|
|
gout |
|
|
nephrolithiasis, uric acid |
|
|
persistent fetal circulation syndrome |
|
|
tubulointerstitial kidney disease, autosomal dominant, 1 |
|
|